Trial
NCT04325633
Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
COVID-19
Intervention
1: Naproxen
Why stopped
Stop inclusions for insufficient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-25